This inventor holds 1 USPTO granted patent. Top assignees: The Open University, University Health Network. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 8 
1 out of 312 
Years Active: 2011
Title: The Innovations of Jean Gariepy
Introduction
Jean Gariepy is a notable inventor based in California, recognized for his contributions to the field of biotechnology. He holds a patent that focuses on aptamers directed to MUC1, which are crucial in the treatment and diagnosis of conditions associated with elevated production of MUC1. His work has significant implications for medical research and therapeutic applications.
Latest Patents
Jean Gariepy's most recent patent is titled "Aptamers directed to MUC1." This patent describes aptamers against the glycosylated form of MUC1, highlighting their potential use in diagnosing and treating various medical conditions. The innovation represents a significant advancement in targeted therapies and diagnostic tools.
Career Highlights
Throughout his career, Jean Gariepy has worked with esteemed institutions such as The Open University and the University Health Network. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to the advancement of medical science.
Collaborations
Jean has collaborated with notable colleagues, including Sotiris Missailidis and Catia Sofia Matos Ferreira. These partnerships have fostered a collaborative environment that enhances research and innovation in their respective fields.
Conclusion
Jean Gariepy's work exemplifies the impact of innovation in biotechnology, particularly through his patent on MUC1 aptamers. His contributions continue to influence the landscape of medical research and treatment options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile